CD86 and cardiovascular disorder: CD86, driving the atherogenic process [74] in the adaptive immune system, and BATF relate MS disease with cardiovascular disease risk factors, high-density lipoprotein cholesterol (CD86), and systolic blood pressure (BATF) [15].